Nurse Practitioner in Harleysville, PA Accepting Medicare
7 Nurse Practitioner nurses found. Showing 1 - 7
 Christine M Mcguinness, CRNP Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 682 Main St, Harleysville, PA 19438 Phone: 215-256-8040 Fax: 215-256-4857 |
Karen M Pavlick, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 484 Harleysville Pike, Harleysville, PA 19438 Phone: 215-256-8040 |
Shannon Romano, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 658 Harleysville Pike, Suite 120, Harleysville, PA 19438 Phone: 215-256-9655 Fax: 215-256-9868 |
Jeanne Ragan Defrangesco, CRNP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 1505 Breckenridge Pl, Harleysville, PA 19438 Phone: 215-393-9589 |
 Charles C Thornton, PMHNP-BC Nurse Practitioner - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 681 Harleysville Pike, Harleysville, PA 19438 Phone: 267-933-5205 Fax: 267-932-8660 |
Janet Landis, PMHNP, B.C. Nurse Practitioner - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2281 Schlosser Rd, Harleysville, PA 19438 Phone: 610-955-9914 |
Adjoa Amoah, NP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 672 Main St Ste 1, Harleysville, PA 19438 Phone: 267-500-1170 Fax: 267-500-1176 |
News Archive
Social isolation and low mood accelerate coronary disease in women
A study published in the 2006 March issue of Psychotherapy & Psychosomatics by a Swedish group of investigators points to the effects of social isolation and low mood on the progression of coronary disease.
Addition of ultrasound and MRI to annual mammography effectively detects incident breast cancers
The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident breast cancers, according to a study in the April 4 issue of JAMA.
Forest Laboratories to develop and distribute the novel beta blocker Bystolic (nebivolol)
Mylan Inc. has announced that it and Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. have amended their January 2006 agreement to commercialize, develop and distribute the novel beta blocker Bystolic (nebivolol), which is currently approved in the United States for the treatment of hypertension.
COPD patients are more oliley to suffre from depression
Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall healthcare burden for the COPD population.
Gleevec shows significant overall survival benefit for patients w/ GIST after 3 years of adjuvant treatment vs. 1 year
Novartis announced new data today showing a significant improvement in both recurrence-free survival and overall survival for patients taking Gleevec® (imatinib mesylate)* tablets for three years after surgery to remove KIT (CD117)-positive gastrointestinal stromal tumors (KIT+ GIST) compared to one year of treatment. These data will be presented at the 47th American Society of Clinical Oncology (ASCO) plenary session on Sunday, June 5.
› Verified 6 days ago
Nurse Practitioner
Registered Nurse
Physician Assistant
Advanced Practice Midwife
Licensed Practical Nurse